CollPlant Biotechnologies Cash Flow Statement (2019-2025) | CLGN

Cash Flow Statement Dec2019 Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Operating Activities
Share-based Compensation (Quarter) 0.87M
Gains from Investment Securities (Quarter) 0.02M0.22M0.16M0.03M0.02M
Non-cash Items (Quarter) 1.15M0.31M0.01M